New Court Proceedings - March 2019

In a significant and disappointing turn of events, the remaining sexual assault charges against former megachurch pastor Bruxy Cavey have been withdrawn in a Hamilton courtroom.

The British Columbia Court of Appeal has left open the possibility that pharmaceutical manufacturers may owe a duty of care to develop safer alternatives to their existing products, even when those products are properly approved and labeled. This decision in Gilead Sciences, Inc. v. I.F. contrasts sharply with a recent California Supreme Court ruling that rejected such a "duty to innovate," potentially setting Canada on a divergent path in product liability law.

Following are our summaries of the civil decisions of the Court of Appeal for Ontario for the week of September 14, 2026.

Ontario's Rules of Civil Procedure now include strict amendments requiring lawyers and expert witnesses to certify the authenticity of every citation and authority used in court materials. These new anti-hallucination provisions impose significant penalties for presenting AI-generated fabricated authorities, fundamentally shifting accountability for artificial intelligence use in litigation.

A five-year-old firmware defect in Coldcard hardware wallets has enabled attackers to systematically drain an estimated $116 million in Bitcoin from over 5,200 victims since July 2026. This unprecedented exploit raises critical questions about manufacturer liability and creates two distinct legal pathways for recovery: blockchain tracing against the perpetrators and potential litigation against Canadian manufacturer Coinkite for product defects that undermined the fundamental security promise of devices mar

The Supreme Court of Canada has clarified the legal test for spoliation, establishing a four-part framework that litigants must understand when preserving evidence. This doctrine, rooted in ancient Roman law, creates a mandatory presumption against parties who intentionally destroy or suppress relevant evidence, with courts now empowered to impose severe but proportionate remedies based on the magnitude of the misconduct.

Torts, Defamation, Civil Procedure, Anti-SLAPP, Damages, Costs, Self-Represented Litigants, Full Indemnity, Courts of Justice Act, R.S.O. 1990, c.C.43, s. 136.1, Human Rights...

Deepfakes are reaching courts. Learn how a U.S. case dismissed for AI-generated evidence and Canadian authentication rules are changing what litigators must do now.

In Cycle Toronto v Ontario (Attorney General), 2026 ONCA 582, the Ontario Court of Appeal overturned a lower court ruling preventing the government of Ontario from ripping out 19 kilometers of protected bike lines along three major Toronto roadways. The decision underlines the limited role of the courts in reviewing policy-based government decisions.

For many people in Ontario family court, the first case conference can feel uncertain. You may wonder whether anything meaningful can happen at this early stage, especially if disclosure is missing, support is needed, or temporary arrangements are required. While a case conference is not a trial, it can still be an important step in getting the case organized and moving forward.

COLD-FX is a top-selling natural health product in Canada, with sales topping nearly $120-million as recently as 2011, according to a November 15, 2015 Globe and Mail article, "Why COLD-FX is too good to be true".

For a Canadian patent application to be examined, an applicant must file a request for examination with the Canadian Intellectual Property Office (CIPO). In most cases, the order in which applications are examined is based on the order that the requests for examination are received. An applicant may be able to accelerate examination of their patent application through several existing mechanisms, including advancing examination via special order, accelerating examination of applications related to green technology, and the Patent Prosecution Highway (PPH).

On December 20, 2023, the Federal Court issued a Notice to the Parties and the Profession regarding the use of artificial intelligence in court proceedings. In line with several other provincial

Patented Medicine Prices Review Board's multi-stakeholder Steering Committee holds first meeting

The Pharmaceutical and Life Sciences Sector Task Force has released its final report addressing Canada's challenges in medication access, regulatory processes, and life sciences competitiveness. The report examines structural issues including lengthy reimbursement pathways, underperforming clinical trial environments, and erosion of domestic investment, while proposing 39 recommendation areas to strengthen Canada's health sovereignty and industrial strategy.

Today, the German government ratified the Unified Patent Court Agreement (UPCA), setting in motion significant changes to the patent system in Europe.

On February 15, 2017, the European Parliament voted to approve the Canada-EU Comprehensive Economic and Trade Agreement (CETA).

This article will discuss the broad powers of search of electronic devices held by US and Canadian border officials.

On March 13, 2019, the Competition Bureau ("Bureau") published the final version of its updated Intellectual Property Enforcement Guidelines (IPEGs).

In view of the ongoing COVID-19 pandemic, the Canadian Intellectual Property Office (CIPO) has further extended patent, trademark, and industrial design